READ THE FULL PUBLICATION here (Adobe Acrobat Reader required to view this article).
READ THE FULL PUBLICATION here (Adobe Acrobat Reader required to view this article).
READ THE FULL PUBLICATION here (Adobe Acrobat Reader required to view this article).
POR JUAN LUIS SERRANO Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic entry is controlled increasingly […]
READ FULL ARTICLE HERE (Adobe Acrobat Reader required)